首页>
外国专利>
SKI 606 as a src kinase inhibitor for the treatment of osteolytic lesions
SKI 606 as a src kinase inhibitor for the treatment of osteolytic lesions
展开▼
机译:SKI 606作为治疗溶骨性病变的src激酶抑制剂
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention include methods and compositions for treating bone-resorbing diseases or bone resorption related to a pathologic condition generally, including, but not limited to osteoporosis, arthritis, rheumatoid arthritis, cancer metastases to the bone, bone cancer, hypercalcemia, osteolytic lesions with orthopedic implants, Paget's disease, and bone loss associated with hyperparathyroidism. Representative cancers include, but are not limited to breast cancer, prostrate cancer, colon cancer, endometrial cancer, multiple myeloma, renal cell carcinoma, heck and neck cancers, and cervical carcinoma. Arthritic conditions include, but are not limited to adjuvant-, collagen-, bacterial- and antigen-induced arthritis, particularly rheumatoid arthritis.
展开▼